Variable | Low-value group (n = 40) | High-value group (n = 14) |
---|---|---|
AFD | ||
 Deaths—no. (%)a | 4 | 6 |
 Data censoredb | 36 | 8 |
 Median overall survival—mo (95% CI) | NE | NE |
 The overall survival (95% CI) by Kaplan–Meier estimation | ||
 12 mo | 95% (88.5–100) | 78.6% (59.8–100) |
 31 mo | 89.7% (80.6–99.8) | 64.3% (43.5–95) |
 35 mo | NA | 56.2% (35.2–90) |
TMB | ||
 Deaths—no. (%)a | 5 | 5 |
 Data censoredb | 35 | 9 |
 Median overall survival—mo (95% CI) | NE | NE |
 The overall survival (95% CI) by Kaplan–Meier estimation | ||
 13 mo | 92.5(84.7–100) | 78.6 (59.8–100) |
 31 mo | 89.9 (80.9–99.8) | 62.5 (41–95.3) |
 35 mo | 87.1 (77.2–98.3) | NA |